What is the ticker symbol for Co-Diagnostics?

Co-Diagnostics trades under the ticker CODX on NASDAQ.

What sector does Co-Diagnostics operate in?

Co-Diagnostics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CODX in a portfolio?

PortView shows CODX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Co-Diagnostics (CODX) Stock Analysis

NASDAQHealthcareBiotechnology

$1.18-0.84%

1-year price historyRange $1.10 – $37.80

52-week range$1.18

$0.94$46.50

What Co-Diagnostics does

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Key metrics

Market cap

$1.32M

P/E (TTM)

-0.05

EPS (TTM)

$-25.44

Beta

2.88

Dividend yield

0.00%

Revenue / share

$0.17

50-day avg

$2.00

200-day avg

$3.78

52-week high

$46.50

52-week low

$0.94

CEO

Dwight Egan

ETFs linked to CODX

Broad-market and Healthcare sector ETFs an investor holding Co-Diagnostics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CODX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CODX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Co-Diagnostics?: Co-Diagnostics trades under the ticker CODX on NASDAQ.
Which exchange is CODX listed on?: CODX is listed on NASDAQ.
What sector does Co-Diagnostics operate in?: Co-Diagnostics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CODX in a portfolio?: PortView shows CODX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.